Cargando…

Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study

BACKGROUND: Long-term survival and cause-specific mortality of patients who start tuberculosis treatment is rarely described. We aimed to assess the long-term survival of these patients and evaluate the association between vulnerable conditions (social, health behaviours, and comorbidities) and caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranzani, Otavio T, Rodrigues, Laura C, Bombarda, Sidney, Minto, Cátia M, Waldman, Eliseu A, Carvalho, Carlos R R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928568/
https://www.ncbi.nlm.nih.gov/pubmed/31676242
http://dx.doi.org/10.1016/S1473-3099(19)30518-3
_version_ 1783482503198146560
author Ranzani, Otavio T
Rodrigues, Laura C
Bombarda, Sidney
Minto, Cátia M
Waldman, Eliseu A
Carvalho, Carlos R R
author_facet Ranzani, Otavio T
Rodrigues, Laura C
Bombarda, Sidney
Minto, Cátia M
Waldman, Eliseu A
Carvalho, Carlos R R
author_sort Ranzani, Otavio T
collection PubMed
description BACKGROUND: Long-term survival and cause-specific mortality of patients who start tuberculosis treatment is rarely described. We aimed to assess the long-term survival of these patients and evaluate the association between vulnerable conditions (social, health behaviours, and comorbidities) and cause-specific mortality in a country with a high burden of tuberculosis. METHODS: In this population-based, longitudinal study in São Paulo state, Brazil, we described the 5-year survival of patients who were newly diagnosed with tuberculosis in 2010. We included patients with newly-diagnosed tuberculosis, aged 15 years or older, and notified to the São Paulo State Tuberculosis Program in 2010. We excluded patients whose diagnosis had changed during follow-up (ie, they did not have tuberculosis) and patients who had multidrug-resistant (MDR) tuberculosis. We selected our population with tuberculosis from the dedicated electronic system TBweb. Our primary objective was to estimate the excess mortality over 5 years and within the group who survived the first year, compared with the general São Paulo state population. We also estimated the association between social vulnerability (imprisonment and homelessness), health behaviours (alcohol and drug use), and comorbidities (diabetes and mental disorders) with all-cause and cause-specific mortality. We used the competing risk analysis framework, estimating cause-specific hazard ratios (HRs) adjusted for potential confounding factors. FINDINGS: In 2010, there were 19 252 notifications of tuberculosis cases. We excluded 550 cases as patients were younger than 15 years, 556 cases that were not tuberculosis, 2597 retreatments, and 48 cases of MDR tuberculosis, resulting in a final cohort of 15 501 patients with tuberculosis. Over a period of 5 years from tuberculosis diagnosis, 2660 (17%) of 15 501 patients died. Compared with the source population, matched by age, sex, and calendar year, the standardised mortality ratio was 6·47 (95% CI 6·22–6·73) over 5 years and 3·93 (3·71–4·17) among those who survived the first year. 1197 (45%) of 2660 deaths were due to infection. Homelessness and alcohol and drug use were associated with death from infection (adjusted cause-specific HR 1·60, 95% CI 1·39–1·85), cardiovascular (1·43, 1·06–1·95), and external or ill-defined causes of death (1·80, 1·37–2·36). Diabetes was associated with deaths from cardiovascular causes (1·70, 1·23–2·35). INTERPRETATION: Patients newly diagnosed with tuberculosis were at a higher risk of death than were the source population, even after tuberculosis treatment. Post-tuberculosis sequelae and vulnerability are associated with excess mortality and must be addressed to mitigate the tuberculosis burden worldwide. FUNDING: Wellcome Trust.
format Online
Article
Text
id pubmed-6928568
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Science ;, The Lancet Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-69285682020-01-01 Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study Ranzani, Otavio T Rodrigues, Laura C Bombarda, Sidney Minto, Cátia M Waldman, Eliseu A Carvalho, Carlos R R Lancet Infect Dis Article BACKGROUND: Long-term survival and cause-specific mortality of patients who start tuberculosis treatment is rarely described. We aimed to assess the long-term survival of these patients and evaluate the association between vulnerable conditions (social, health behaviours, and comorbidities) and cause-specific mortality in a country with a high burden of tuberculosis. METHODS: In this population-based, longitudinal study in São Paulo state, Brazil, we described the 5-year survival of patients who were newly diagnosed with tuberculosis in 2010. We included patients with newly-diagnosed tuberculosis, aged 15 years or older, and notified to the São Paulo State Tuberculosis Program in 2010. We excluded patients whose diagnosis had changed during follow-up (ie, they did not have tuberculosis) and patients who had multidrug-resistant (MDR) tuberculosis. We selected our population with tuberculosis from the dedicated electronic system TBweb. Our primary objective was to estimate the excess mortality over 5 years and within the group who survived the first year, compared with the general São Paulo state population. We also estimated the association between social vulnerability (imprisonment and homelessness), health behaviours (alcohol and drug use), and comorbidities (diabetes and mental disorders) with all-cause and cause-specific mortality. We used the competing risk analysis framework, estimating cause-specific hazard ratios (HRs) adjusted for potential confounding factors. FINDINGS: In 2010, there were 19 252 notifications of tuberculosis cases. We excluded 550 cases as patients were younger than 15 years, 556 cases that were not tuberculosis, 2597 retreatments, and 48 cases of MDR tuberculosis, resulting in a final cohort of 15 501 patients with tuberculosis. Over a period of 5 years from tuberculosis diagnosis, 2660 (17%) of 15 501 patients died. Compared with the source population, matched by age, sex, and calendar year, the standardised mortality ratio was 6·47 (95% CI 6·22–6·73) over 5 years and 3·93 (3·71–4·17) among those who survived the first year. 1197 (45%) of 2660 deaths were due to infection. Homelessness and alcohol and drug use were associated with death from infection (adjusted cause-specific HR 1·60, 95% CI 1·39–1·85), cardiovascular (1·43, 1·06–1·95), and external or ill-defined causes of death (1·80, 1·37–2·36). Diabetes was associated with deaths from cardiovascular causes (1·70, 1·23–2·35). INTERPRETATION: Patients newly diagnosed with tuberculosis were at a higher risk of death than were the source population, even after tuberculosis treatment. Post-tuberculosis sequelae and vulnerability are associated with excess mortality and must be addressed to mitigate the tuberculosis burden worldwide. FUNDING: Wellcome Trust. Elsevier Science ;, The Lancet Pub. Group 2020-01 /pmc/articles/PMC6928568/ /pubmed/31676242 http://dx.doi.org/10.1016/S1473-3099(19)30518-3 Text en © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ranzani, Otavio T
Rodrigues, Laura C
Bombarda, Sidney
Minto, Cátia M
Waldman, Eliseu A
Carvalho, Carlos R R
Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study
title Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study
title_full Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study
title_fullStr Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study
title_full_unstemmed Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study
title_short Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study
title_sort long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in são paulo state, brazil, 2010–15: a population-based, longitudinal study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928568/
https://www.ncbi.nlm.nih.gov/pubmed/31676242
http://dx.doi.org/10.1016/S1473-3099(19)30518-3
work_keys_str_mv AT ranzaniotaviot longtermsurvivalandcausespecificmortalityofpatientsnewlydiagnosedwithtuberculosisinsaopaulostatebrazil201015apopulationbasedlongitudinalstudy
AT rodrigueslaurac longtermsurvivalandcausespecificmortalityofpatientsnewlydiagnosedwithtuberculosisinsaopaulostatebrazil201015apopulationbasedlongitudinalstudy
AT bombardasidney longtermsurvivalandcausespecificmortalityofpatientsnewlydiagnosedwithtuberculosisinsaopaulostatebrazil201015apopulationbasedlongitudinalstudy
AT mintocatiam longtermsurvivalandcausespecificmortalityofpatientsnewlydiagnosedwithtuberculosisinsaopaulostatebrazil201015apopulationbasedlongitudinalstudy
AT waldmaneliseua longtermsurvivalandcausespecificmortalityofpatientsnewlydiagnosedwithtuberculosisinsaopaulostatebrazil201015apopulationbasedlongitudinalstudy
AT carvalhocarlosrr longtermsurvivalandcausespecificmortalityofpatientsnewlydiagnosedwithtuberculosisinsaopaulostatebrazil201015apopulationbasedlongitudinalstudy